Possible antileishmanial effect of recombinant human erythropoietin

Basit Öğe Kaydı
dc.contributor.authorInceboz, T.
dc.contributor.authorBaskin, H.
dc.contributor.authorDogan, Y.
dc.contributor.authorToz, S. Ozensoy
dc.contributor.authorBahar, I. H.
dc.date.accessioned2019-10-27T20:50:06Z
dc.date.available2019-10-27T20:50:06Z
dc.date.issued2009
dc.departmentEge Üniversitesien_US
dc.identifier.endpage186en_US
dc.identifier.issn1360-2276
dc.identifier.startpage186en_US
dc.identifier.urihttps://hdl.handle.net/11454/42951
dc.identifier.volume14en_US
dc.identifier.wosWOS:000269264000519en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwell Publishing, Incen_US
dc.relation.ispartofTropical Medicine & International Healthen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePossible antileishmanial effect of recombinant human erythropoietinen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu